{"blog": [], "keywords": [{"value": "Lung Cancer", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Clinical Trials", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Advertising and Marketing", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Bristol Myers Squibb Company", "name": "organizations", "rank": "4", "is_major": "Y"}, {"value": "Food and Drug Administration", "name": "organizations", "rank": "5", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "6", "is_major": "Y"}], "web_url": "http://www.nytimes.com/2016/08/09/opinion/cancer-drug-ads-vs-cancer-drug-reality.html", "document_type": "article", "byline": {"person": [{"lastname": "JABLOW", "firstname": "Matt", "role": "reported", "organization": "", "rank": 1}], "original": "By MATT JABLOW"}, "type_of_material": "Op-Ed", "multimedia": [{"url": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-thumbWide.jpg", "legacy": {"wide": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-articleLarge.jpg", "legacy": {"xlarge": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-articleLarge.jpg", "xlargeheight": "432", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 432}, {"url": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-thumbStandard-v2.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Opinion", "word_count": "776", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Opdivo didn\u2019t help my wife, or almost anyone else. So why can Bristol-Myers Squibb market it on TV?", "pub_date": "2016-08-09T04:00:00+0000", "news_desk": "OpEd", "headline": {"kicker": "Op-Ed Contributor", "print_headline": "Drug Ads vs. Drug Reality", "main": "Cancer-Drug Ads vs. Cancer-Drug Reality", "content_kicker": "Op-Ed Contributor"}, "print_page": "23", "snippet": "Opdivo didn\u2019t help my wife, or almost anyone else. So why can Bristol-Myers Squibb market it on TV?...", "_id": "57aa4d5a95d0e021d797f79c", "slideshow_credits": null, "abstract": "Op-Ed article by Matt Jablow of insurance company Evergreen Health calls for misleading television advertisements touting benefits of Pharmaceuticals to be pulled from air; cites Bristol-Myers Squibb ad for immunotherapy drug Opdivo for lung cancer patients, noting drug performed poorly in clinical trials."}